Co-proxamol: Not gone yet

New letter from myself and Rich Croker in @bjgp.bsky.social

Despite the formal withdrawal of its marketing authorisation nearly two decades ago, co-proxamol prescribing persists, with tragic results.

Read it at: doi.org/10.3399/bjgp... (full letter in alt text)

OpenPrescribing for Hospitals now has multi-product search!

Suggested by our users once we launched............

Built by us in the open!

Check it out

hospitals.openprescribing.net/analyse/

Here's an example of codeine tabs

An NIHR HTA-funded programme at Bristol looked at this in detail before the pandemic. We wanted to understand what’s actually happening across England.

This policy briefing is good summary of their work www.bristol.ac.uk/policybristo...

Direct Oral Anticoagulants (like apixaban, rivaroxaban etc) are widely used for stroke prevention in AF and treating clots.

They’re clinically similar, but vary a lot in price. NHS recommends using the best value ones.

See website for full "why it matters" and how your NHS organisation is doing

Are hospitals following NHS England’s guidance on best value anticoagulants?

New measure on OpenPrescribing Hospitals:

hospitals.openprescribing.net/measures/bes...

Can the NHS implement new meds quickly?

Some say no......

But Phesgo® shows it can happen overnight.

New OpenPrescribing Hospitals measure:

hospitals.openprescribing.net/measures/phe...

A small but momentous change to the OpenPrescribing homepage this evening.

Hospital medicines data now OPEN for everyone

hospitals.openprescribing.net

We didn't look at med reviews but we did look at some practice factors for association

This policy briefing is good summary of their work

www.bristol.ac.uk/policybristo...

And our OpenSAFELY Community symposium is now open !

#opensafely